Concepedia

Lixia Diao

LD

Statistics

Publications

136

Citations

21.3K

H-Index

69

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

The University of Texas Southwestern Medical Center

Baylor College of Medicine

Huazhong University of Science and Technology

Lixia Diao is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and systems biology.

ORCID

Top concepts

Publications per year

2003–2025

136

Publications

136

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren A. Byers, Lixia Diao, Jing Wang et al. · Clinical Cancer Research · 2012 · 1.1K citations · Full text

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

Limo Chen, Don L. Gibbons, Sangeeta Goswami et al. · Nature Communications · 2014 · 970 citations · Full text

, , +9

Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao et al. · Cancer Discovery · 2015 · 883 citations · Full text

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park et al. · Cancer Cell · 2021 · 864 citations · Full text

, , +11

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

Triparna Sen, B. Leticia Rodriguez, Limo Chen et al. · Cancer Discovery · 2019 · 841 citations · Full text

Rows per page

1–5 of 136